Niagen Bioscience (NAGE) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $12.7 million.
- Niagen Bioscience's Accounts Payables rose 8458.64% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 8458.64%. This contributed to the annual value of $8.5 million for FY2024, which is 1667.32% down from last year.
- Latest data reveals that Niagen Bioscience reported Accounts Payables of $12.7 million as of Q3 2025, which was up 8458.64% from $13.7 million recorded in Q2 2025.
- Niagen Bioscience's Accounts Payables' 5-year high stood at $13.7 million during Q2 2025, with a 5-year trough of $6.9 million in Q3 2024.
- For the 5-year period, Niagen Bioscience's Accounts Payables averaged around $9.8 million, with its median value being $9.9 million (2021).
- As far as peak fluctuations go, Niagen Bioscience's Accounts Payables tumbled by 2495.11% in 2024, and later soared by 8458.64% in 2025.
- Niagen Bioscience's Accounts Payables (Quarter) stood at $10.4 million in 2021, then decreased by 7.14% to $9.7 million in 2022, then grew by 5.71% to $10.2 million in 2023, then decreased by 16.67% to $8.5 million in 2024, then soared by 49.45% to $12.7 million in 2025.
- Its Accounts Payables was $12.7 million in Q3 2025, compared to $13.7 million in Q2 2025 and $10.6 million in Q1 2025.